ECULIZUMAB for Covid-19 treatment: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 35 adverse event reports in the FDA FAERS database where ECULIZUMAB was used for Covid-19 treatment.
Most Reported Side Effects for ECULIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 4,858 | 11.0% | 91 | 944 |
| Off label use | 4,228 | 9.6% | 577 | 658 |
| Haemoglobin decreased | 3,028 | 6.9% | 127 | 1,045 |
| Headache | 2,699 | 6.1% | 56 | 700 |
| Death | 2,221 | 5.0% | 2,221 | 540 |
| Pyrexia | 1,948 | 4.4% | 128 | 1,129 |
| Dyspnoea | 1,819 | 4.1% | 97 | 737 |
| Asthenia | 1,732 | 3.9% | 95 | 627 |
| Drug ineffective | 1,644 | 3.7% | 164 | 472 |
| Nausea | 1,579 | 3.6% | 47 | 516 |
| Malaise | 1,562 | 3.5% | 91 | 591 |
| Platelet count decreased | 1,502 | 3.4% | 111 | 659 |
| Haemolysis | 1,476 | 3.3% | 87 | 557 |
| Hospitalisation | 1,345 | 3.0% | 75 | 1,336 |
| Blood lactate dehydrogenase increased | 1,290 | 2.9% | 79 | 420 |
Other Indications for ECULIZUMAB
Paroxysmal nocturnal haemoglobinuria (12,054)
Haemolytic uraemic syndrome (8,500)
Product used for unknown indication (6,808)
Atypical haemolytic uraemic syndrome (5,848)
Myasthenia gravis (5,715)
Off label use (3,550)
Thrombotic microangiopathy (1,312)
Neuromyelitis optica spectrum disorder (1,097)
C3 glomerulopathy (267)
Transplant rejection (176)
Other Drugs Used for Covid-19 treatment
NIRMATRELVIR\RITONAVIR (44,763)
MOLNUPIRAVIR (3,476)
CASIRIVIMAB\IMDEVIMAB (208)
REMDESIVIR (156)
CILGAVIMAB\TIXAGEVIMAB (146)
BAMLANIVIMAB\ETESEVIMAB (85)
HYDROXYCHLOROQUINE (71)
SOTROVIMAB (69)
BAMLANIVIMAB (66)
DEXAMETHASONE (60)